FT US Pharma and Biotech Summit 2025: Live coverage
We’re back this year, this time virtually attending the FT US Pharma and Biotech Summit in New York City, a one-day event where top pharma execs will come together to discuss the major tren
Modelling biologics: Challenges and opportunities, with Dr D...
From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Novo Nordisk's dropping share price spells the end for CEO
Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
Incyte's PD-1 drug brings immunotherapy to anal cancer
Incyte has broken new ground in immuno-oncology, getting FDA approval for its Zynyz drug as a treatment for anal cancer
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
4th Annual Process Development for Cell Therapies Summit
Driving Process Robustness, Scalability, Speed & Affordability
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
Injectable Drug Delivery 2025 – Driving Innovation Through C...
Press Release: Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration LONDON, UK – 24–25 June 2025
4th In Vivo Cell Engineering & Gene Editing Summit
This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
6th Gene Therapy Analytical Development Summit Europe
Join 24+ expert speakers and over 90 industry stakeholders to unlock analytical strategies that elevate your development programmes,...